United States Clinical Nutrition Market Insights Forecasts to 2033

• United States Clinical Nutrition Market Size was valued at USD 12.2 Billion in 2023.
• The United Clinical Nutrition States Market Size is growing at a CAGR of 12.75% from 2023 to 2033
• The U.S Clinical Nutrition Market Size is expected to reach USD 40.5 Billion by 2033

The United States Clinical Nutrition Market is anticipated to exceed USD 40.5 Billion by 2033, Growing at a CAGR of 12.75% from 2023 to 2033.

The growing metabolic disorders and chronic diseases, high junk food consumption (malnourishment), rising geriatric population, increasing incidence of pre-mature birth & birth rate, and increasing adoption of home healthcare are driving the growth of the clinical nutrition market in the United States.     

Market Overview

Clinical nutrition is defined as the application of the principles of nutrition science and medical practice to the diagnosis, treatment, and prevention of human disease caused by the metabolic imbalance of nutrients. It includes prevention, diagnosis, and management of nutritional changes in patients linked to chronic diseases primarily in healthcare. Nutrition is a critical part of health and development that augments infant, child, and maternal health, strong immune systems, safe pregnancy and childbirth, and lower risk of non-communicable diseases such as diabetes and cardiovascular disease. Macronutrient and micronutrient levels in the body can be impacted by several complications and disorders of nutrient deficiencies which can be caused by inadequate dietary intake, acute or chronic medical disorders, drugs, altered nutrient metabolism, or a combination of these factors. According to the WHO, tobacco use, physical inactivity, and unhealthy diet are the three most common modifiable risk factors of chronic disease. Chronic disease is one of the most challenging factors of nutrition deficiency. Clinical nutrition is used to develop dietary plans that promote heart-healthy eating habits and reduce the risk of complications. The use of digital technology in clinical nutrition is gaining prevalence, with AI being used in diet optimization, food image recognition, risk prediction, and diet pattern analysis. 

Report Coverage

This research report categorizes the market for the US clinical nutrition market based on various segments and regions and forecasts revenue growth and analyzes trends in each submarket. The report analyses the key growth drivers, opportunities, and challenges influencing the clinical nutrition market. Recent market developments and competitive strategies such as expansion, product launch, and development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key market players and analyses their core competencies in each sub-segment of the clinical nutrition market.

Driving Factors

Nutrient deficiency can contribute to the development of diseases or other health problems like inadequate vitamin D and/or calcium status, impacting bone development/maintenance, as well as inadequate vitamin K status affecting blood coagulation. The growing number of metabolic disorders and other chronic diseases are enhancing the market growth of clinical nutrition. In developed countries, there are rising cases of malnutrition due to several factors like reduced dietary intake, absorption of macro/micronutrients, increased loss, or altered requirements leading to enhanced market demand. The recommendations for clinical nutrition in older persons to prevent and/or treat malnutrition. The rising geriatric population positively affects the growth of the clinical nutrition market. The increasing incidence of pre-mature birth & birth rate leads to an enhanced market as appropriate nutrition is essential for the growth and development of preterm infants. Further, the rising adoption of home healthcare is also responsible for increasing the clinical nutrition market.

Restraining Factors

Stringent government regulations and a lack of awareness about clinical nutrition are restraining the market growth of clinical nutrition.

Market Segmentation

The United States Clinical Nutrition Market share is classified into product, consumer, and application.

• The infant nutrition segment dominates the market with the largest market share through the forecast period.

The United States clinical nutrition market is segmented by product into infant nutrition, enteral nutrition, and parenteral nutrition. Among these, the infant nutrition segment dominates the market with the largest market share through the forecast period. As per estimation in 2020, about 13.4 million babies that is 1 in 10 of all live births are born before 37 full weeks of pregnancy. Thus, the increasing prevalence of premature birth increases the demand for infant nutrition. Further, the growing concern regarding infant nutrition positively affects the market growth.

• The metabolic segment dominates the market with the largest market share through the forecast period.

The United States clinical nutrition market is segmented by application into metabolic disorders, and neurological diseases. Among these, the metabolic segment dominates the market with the largest market share through the forecast period. The increasing cases of metabolic diseases are responsible for enhancing the market. Other factors like obesity, diabetes, malnutrition, and cardiovascular diseases increase market demand in the metabolic segment. Nutrition therapy, as part of a comprehensive lifestyle intervention, may improve obesity and insulin resistance, which play key roles in its pathogenesis.

• The pediatric segment accounted for the largest market share of the United States clinical nutrition market during the forecast period.

The United States clinical nutrition market is segmented by consumer into pediatric and adult. Among these, the pediatric segment accounted for the largest market share of the United States clinical nutrition market during the forecast period. The pediatric segment includes infants, children, and adolescents. Nutrition has a pivotal role in growth, development, and overall health during these stages. Pediatric clinical nutrition focuses on promoting balanced diets, addressing nutrient deficiencies, and preventing childhood obesity and related health problems.

Competitive Analysis:

The report offers the appropriate analysis of the key organizations/companies involved within the US clinical nutrition market along with a comparative evaluation primarily based on their product offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.

List of Key Companies

• Abbott Laboratories
• Nestle Health Sciences SA
• Mead Johnson
• Pfizer
• Meiji Holdings Co. Ltd.
• Fresenius Kabi
• Hero Nutritionals Inc.
• B Braun Melsungen AG
• Baxter International Inc. 
• Others

Key Target Audience

• Market Players
• Investors
• End-users
• Government Authorities 
• Consulting And Research Firm
• Venture capitalists
• Value-Added Resellers (VARs)

Recent developments

• In November 2021, Abbott announced the launch of Similac 360 Total Care, the company's next generation of infant formula with HMOs, major prebiotics structurally identical to those found in human breast milk.

Market Segment

This study forecasts revenue at United States, regional, and country levels from 2020 to 2033. Spherical Insights has segmented the United States Clinical Nutrition Market based on the below-mentioned segments:

United States Clinical Nutrition Market, By Product

• Infant Nutrition
• Enteral Nutrition
• Parenteral Nutrition

United States Clinical Nutrition Market, By Consumer

• Pediatric
• Adult

United States Clinical Nutrition Market, By Application

• Metabolic Disorders
• Neurological Diseases